Growing evidence shows that COVID-19 is associated with an increase in Tako-Tsubo syndrome (TTS) incidence. We collected data from patients hospitalized in our multidisciplinary COVID 19 department who had a diagnosis of TTS during the second and third waves of the pandemic in Italy. We reported four cases of TTS associated with COVID-19. Except for COVID-19, no patient had any classical TTS triggers. The mean age was 72 years (67-81) and all patients had COVID-19-related interstitial pneumonia confirmed by computed tomography. Typical apical ballooning and transitory reduction in left ventricle (LV) systolic function with a complete recovery before discharge were observed in all patients. The mean LV ejection fraction at TTS onset was 42% (40-48%). The electrocardiogram showed ST-segment elevation in two cases, while an evolution with negative T waves and corrected QT prolongation was observed in all patients. Three patients underwent coronary angiography. Two patients had Alzheimer's disease. The time interval from hospital admission to TTS onset was 4 (2-6) days, and the time interval from COVID19 symptom onset to TTS diagnosis was 10 (8-12) days. COVID19 may be a trigger for TTS, though TTS pathophysiology in COVID-19 patients remains unclear, likely due to its multifactorial nature.
The clinical benefit of beta-blocker treatment in patients with a previous myocardial infarction (MI) and without a reduced left ventricular ejection fraction (LVEF) is not established. This study aims at assessing the impact of beta-blocker treatment after an MI based on the type of MI at presentation, the LVEF, and the patient’s sex in the setting of contemporary management of MI. We searched the PubMed and Cochrane Library databases for randomized clinical trials published over last ten years that reported beta-blockers’ impact on prognosis in patients with LVEF > 40%. A meta-analysis was performed to assess the association between the beta-blocker treatment and outcomes in different patient subgroups based on the type at presentation (with ST segment elevation, STEMI, or without ST segment elevation, NSTEMI), LVEF, and sex. In the overall analysis, the association between beta-blocker non-use and the composite endpoint was not statistically significant under the random-effects model. In subgroup analyses, a higher risk with beta-blocker non-use was suggested in NSTEMI and in patients with mildly reduced LVEF in common-effect estimates (NSTEMI: RR 1.13, 95% CI 1.02–1.25; I2 18%; mildly reduced LVEF: RR 1.24, 95% CI 1.03–1.49; I2 0%), whereas corresponding random-effects estimates were not consistently significant. No clear association was observed in STEMI, preserved LVEF, or by sex. In sensitivity analyses excluding the ABYSS withdrawal trial, the overall association was attenuated and remained non-significant (random-effects RR 1.06, 95% CI 0.84–1.33; I2 35%). Long-term beta-blocker therapy after myocardial infarction showed no clear overall benefit or harm across contemporary randomized trials. Possible signals of benefit in selected subgroups warrant confirmation in adequately powered studies with standardized endpoints.
Background: Since the start of the conflict in Ukraine, a progressive migration flow from war regions to many European countries has been observed, with an unavoidable impact on health care systems of the individual host states. With this work, we aimed to evaluate the trend over time in the demand of cardiological services of Ukrainian patients in our centre. Methods: We performed a retrospective analysis of the medical records of our Cardiology Department from January 2015 to December 2022. All cardiological services provided to Ukrainian patients, both in outpatient and inpatient setting, were counted. The average number of services performed annually from 2015 to 2021 was then compared with that observed in 2022. Results: The average number of cardiology services annually provided to Ukrainian patients during 2015–2021 was 18.7 vs 60 in 2022. In 2022, compared to the previous period, the total number of services performed by our heart centre increased by 246% and the number of hospital admissions by 16.7%. In detail, we observed an increase in performed ECGs (+ 1125%), echocardiograms ( + 465%), Holter ECGs (+88%) and electrophysiological studies (+110%). The average age of Ukrainian patients referred to our centre in 2022 is similar to that of previous years (59.9±2.4 vs 59.8±2.3 years). Finally, an increase in the number of male subjects, who needed our cardiological services annually, was observed (74% vs 22.5%). Conclusions: With the start of the war in Ukraine, compared to the previous six years, we observed an increase in the number of services provided to Ukrainian patients in our centre. These patients were mainly male, both in outpatient and inpatient settings. The NHS will have to cope with this demand, which is bound to increase over time, by promoting and facilitating the access to care for refugee patients not resident in Italy. These preliminary data can be a starting point for a larger multi–centre analysis, which may be helpful to understand the extent of this new challenge.
15 December 2023 in Monaldi Archives for Chest Disease
Dear Editor, We thank Dr. Finsterer and Dr. Stollberger for their interest in our published manuscript which is focused on the collected data from patients hospitalized in our multidisciplinary COVID-19 department who experienced a Tako-Tsubo syndrome (TTS) during the second and third wave of the pandemic...